---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-047253"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2021-09-08T23:59:59+00:00"
generated_at: "2026-06-29T05:15:26.532378+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Finch Therapeutics appoints Marc Blaustein as COO effective Sept 8

## Summary
- Marc Blaustein appointed COO, effective September 8, 2021.
- Base salary of $400,000; target bonus of 40% of base salary; options for 150,000 shares vesting over 4 years.
- Blaustein brings 20+ years biopharma experience, including roles at Dyax, Alkermes, and as CEO of NED Biosystems.
- CEO Mark Smith says Blaustein's operational expertise will be valuable as Finch enters next phase of growth.
- Severance includes 9 months salary (non-CIC) or 12 months salary (CIC) plus equity acceleration.

## SEC filing metadata
- accession: 0001564590-21-047253
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2021-09-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000156459021047253/0001564590-21-047253-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000156459021047253/fnch-8k_20210908.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-047253
- JSON: https://secwatch.observer/filing/0001564590-21-047253.json
- Plain text: https://secwatch.observer/filing/0001564590-21-047253.txt

## Key facts
- Executive change
  Marc Blaustein was appointed as Chief Operating Officer at Finch Therapeutics Group, Inc..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: appointed Marc Blaustein to serve as the Company’s Chief Operating Officer, effective September 8, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733257/000156459021047253/0001564590-21-047253-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.